(Q43562176)

24 November 2017

title

Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). (English)

1 reference

24 November 2017

3

1 reference

24 November 2017

Conacher M

1

1 reference

24 November 2017

Alexander J

series ordinal

2

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

19

1 reference

24 November 2017

issue

20-22

1 reference

24 November 2017

page(s)

2965-2974

1 reference

Oral vaccine models: multiple delivery systems employing tetanus toxoid.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Optimal delivery of vaccines: clinical pharmacokinetic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

1 reference

7 January 2021

Oral immunization with influenza virus in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Mucosal immunoadjuvant activity of liposomes: role of alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Studies on the Mechanism of Bile Salt-Induced Liposomal Membrane Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Accurate determination of adjuvant-associated protein or peptide by ninhydrin assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

The stability of liposomes in vitro to pH, bile salts and pancreatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Membranes and bile formation. Composition of several mammalian biles and their membrane-damaging properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Activation patterns of murine T cells after oral administration of an enterocoated soluble antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

ISCOMS — a novel strategy for mucosal immunization?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Biodegradable microparticles for oral immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

The role of IL-10 in crossregulation of TH1 and TH2 responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Enteric immunization of mice against influenza with recombinant vaccinia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Secretory antibody following oral influenza immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Improvement of inactivated influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

IgG isotype distribution of local and systemic immune responses induced by influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

IgG2a restriction of murine antibodies elicited by viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

10.1016/S0264-410X(00)00537-5

Identifiers

DOI

1 reference

24 November 2017

1 reference